Evidence map›Paper›PMID 40767027›Full record

ArticleJournal of extracellular vesicles2025

Exomeres From Adventitial Fibroblasts of Spontaneously Hypertensive Rats Promote Vascular Remodelling via Transferring Osteopontin.

Jing-Xiao Wang, Xiao-Yu Xu, Hong-Ke Dong, Yi-Ming Wang, Min Dai, Bing Zhou, Yue-Hua Li, Guo-Qing Zhu, Xiao-Qing Xiong

Abstract read
In one paragraph

Article in Journal of extracellular vesicles, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jing-Xiao WangKey Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, China.
Xiao-Yu XuKey Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, China.
Hong-Ke DongKey Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, China.
Yi-Ming WangKey Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, China.
Min DaiKey Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, China.
Bing ZhouDepartment of Pathology, Yijishan Hospital, The First Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, China.
Yue-Hua LiDepartment of Pathophysiology, Nanjing Medical University, Nanjing, Jiangsu, China.
Guo-Qing ZhuKey Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, China.ORCID https://orcid.org/0000-0002-3132-9592
Xiao-Qing XiongKey Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Department of Physiology, Nanjing Medical University, Nanjing, Jiangsu, China.ORCID https://orcid.org/0000-0003-4143-5097

Funding

National Natural Science Foundation of China 31871148National Natural Science Foundation of China 32071106National Natural Science Foundation of China 82270483Postgraduate Research & Practice Innovation Program of Jiangsu Province JX10114130Science Foundation of Anhui Provincial Education Department 2023AH051779
6 · The paper itself

Abstract

Vascular adventitial fibroblasts (VAFs) contribute to vascular remodelling in hypertension. However, the mechanisms by which VAFs regulate vascular smooth muscle cells (VSMCs) in vascular remodelling are not well known. Here we report the crucial roles of extracellular nanoparticles exomeres (EMs) derived from VAFs in promoting VSMCs proliferation, migration and vascular remodelling in normotensive Wistar-Kyoto rats (WKY) and spontaneously hypertensive rats (SHR). VSMCs' proliferation and migration were enhanced by EMs of SHR via the uptake of EMs in VSMCs, but not by EMs of WKY. Proteomics analysis showed that increased osteopontin (OPN) content may be responsible for the roles of EMs of SHR, which was confirmed by the fact that EMs of SHR pretreated with OPN knockdown lost their roles in promoting VSMCs proliferation and migration. OPN successively promoted the phosphorylation of FAK, PI3K and AKT via acting on integrin αVβ3. Inhibition of integrin αVβ3, FAK, PI3K or AKT almost abolished the effects of EMs of SHR on VSMCs proliferation and migration. Knockdown of OPN in the carotid artery attenuated local vascular remodelling in SHR. Repetitive intravenous injection of EMs of SHR increased blood pressure and promoted vascular remodelling in WKY and SHR. We conclude that EMs from VAFs of SHR promote VSMCs proliferation, migration and vascular remodelling via transferring OPN and subsequently activating integrin αVβ3/FAK/PI3K/AKT signalling pathway.

Indexed as

AdventitiaExtracellular VesiclesFibroblastsHypertensionOsteopontinVascular RemodelingAnimalsCell MovementCell ProliferationCells, CulturedIntegrin alphaVbeta3MaleMuscle, Smooth, VascularMyocytes, Smooth MuscleRatsRats, Inbred SHRIntegrin alphaVbeta3OsteopontinSpp1 protein, ratexomerehypertensionosteopontinvascular adventitial fibroblastvascular remodellingvascular smooth muscle cell

Identifiers

PMID40767027
PMCPMC12326188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.